Pharmaceutical Technology

JUNE 29, 2022

Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications. Novozymes has a long legacy of enzyme discovery and the ability to genetically engineer these speciality enzymes to be superior. And it’s within the family – Novozymes!”.

Drugs 295

Drugs Gene Therapy Manufacturing Production 295

Drug Discovery World

NOVEMBER 27, 2023

Anis also serves on the scientific and editorial advisory board of Genetic Engineering News , Mary Ann Liebert, Inc. He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School and a PhD in Virology/Molecular Biology.

Production 59

Production Engineer Gene Editing Gene 59

The Pharma Data

SEPTEMBER 1, 2021

Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. The engineered cells reduced inflammation and prevented a type of damage to bone, known as bone erosion, in a mouse model of rheumatoid arthritis. million adults in the United States.

Drugs 52

Drugs Engineer Drug Delivery Gene 52

pharmaphorum

SEPTEMBER 13, 2022

Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. However, myelodysplastic syndromes and myeloproliferative neoplasms are also prominent types of blood cancer.

Genome Project 98

Genome Project Genome Genomics DNA 98

Drug Discovery World

FEBRUARY 15, 2023

Genetically engineered mouse models (GEMM) recapitulate the stromal biology of different human cancers including the tumour microenvironment that regulates the disease process. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med 2017;9:137–53.doi:10.15252/emmm.201606857pmid:[link]

Research 52

Research In-Vitro In-Vivo Development 52

Drug Discovery World

NOVEMBER 9, 2023

Alessa Schaffrath, Doctoral Student, UKE Hamburg, on: ‘Transgenic llama mice – a fast and flexible single domain discovery tool’. Marine Houdou, Genetic Engineering Specialist, Polyplus, on: ‘From modular DNA assembly to recombinant protein production at Polyplus’.

Engineer 52

Engineer Antibody Protein In-Vivo 52